The majority of published clinical case series on mad honey poisoning originate from emergency departments in northeastern Turkey, particularly hospitals serving Rize, Trabzon, and surrounding Black Sea provinces. This geographic concentration reflects both the highest endemic production of deli bal in the world and the long-standing medical awareness of grayanotoxin poisoning as a distinct clinical entity in regional emergency medicine. Turkish emergency physicians have published the most extensive characterisation of the condition’s clinical presentation, management, and outcome of any medical community globally.
The landmark case series that established the clinical pattern of deli bal poisoning in the modern emergency medicine literature were published from the 1990s onward, with several significant series from Rize and Trabzon hospitals appearing between 2000 and 2020. These series collectively describe hundreds of cases and represent the foundation of current clinical understanding.
Key Takeaways
- The Black Sea region of Turkey (Rize, Trabzon provinces) is the source of the world’s largest and most comprehensive clinical case series on mad honey poisoning.
- Typical patients are middle-aged to older adults who consumed deli bal intentionally in a traditional medicinal context, not accidental poisonings.
- Cardinal presenting features are bradycardia (>90% of symptomatic cases), hypotension, nausea/vomiting, and dizziness; onset typically 1–4 hours post-consumption.
- Atropine is effective in the majority of cases; temporary pacing is required in approximately 5–10% of hospitalised presentations (those with high-grade AV block).
- No deaths from isolated mad honey poisoning in healthy adults are documented in published Black Sea case series; all patients survived to discharge without long-term sequelae.
Patient Profile
The typical patient in published Black Sea case series is an adult male in the fifth or sixth decade of life, consistent with the demographic most likely to consume deli bal in a traditional medicinal context (older adults managing hypertension or using it as a tonic). Female patients are represented in a minority of published cases. Cases in children are rare and typically involve inadvertent consumption through food prepared with honey. Tourists and non-local visitors appear in a minority of cases; this population is disproportionately represented in international case reports (cases outside Turkey or in Turkish cities), where the consumption context is novelty rather than traditional use.
The majority of patients in regional Turkish case series have no documented pre-existing cardiac disease at presentation, which reflects the fact that the product is most frequently consumed by people who believe it to be beneficial for their health rather than harmful to it. However, the subgroup with pre-existing cardiac conditions, hypertension (the condition most frequently cited as the reason for consumption), coronary artery disease, and prior arrhythmia, tends to present with more severe cardiac features.
Clinical Presentation
Across published case series, the cardinal presenting features are bradycardia (present in over 90% of symptomatic cases), hypotension, nausea and vomiting, and dizziness or near-syncope. The typical time from consumption to emergency department presentation is 1–4 hours, reflecting both the 30–60 minute onset of symptoms and the time required to recognise severity and seek care. Most patients arrive conscious and able to provide a consumption history, which is the most important diagnostic information in these cases.
ECG findings documented across case series include sinus bradycardia (most common), first-degree AV block (prolonged PR interval), second-degree AV block, Mobitz types I and II, junctional rhythm, and, in a small number of severe cases, complete third-degree AV block. ST-segment changes and QT prolongation have been described, but are less consistent findings. The ECG pattern in combination with the clinical history of honey consumption is pathognomonic in an endemic area; in non-endemic contexts, the differential diagnosis for this haemodynamic picture is broader.
Treatment and Outcomes
IV atropine is the documented first-line intervention in the large majority of published cases, with dose ranges of 0.5–3 mg and response in most cases within 15 minutes of administration. IV fluid resuscitation is co-administered for hypotension. Most patients are admitted to the emergency observation unit or a monitored bed for 12–24 hours, with discharge following confirmed haemodynamic stability and resolution of ECG changes.
In cases involving complete AV block or inadequate atropine response, temporary transvenous pacing has been used as a definitive intervention. Published case series from high-volume centres report this being required in approximately 5–10% of hospitalised cases. No cases of death from isolated mad honey poisoning in otherwise healthy adults are documented in the peer-reviewed Black Sea case series literature, though mortality in frail patients or those with severe pre-existing cardiac disease cannot be excluded.
The outcome data from regional Turkish case series are uniformly favourable. All documented patients in these series survived to discharge with no reported long-term cardiac sequelae. This outcome profile reinforces the characterisation of grayanotoxin poisoning as a serious but self-limiting toxidrome with excellent prognosis when appropriately managed.
Implications for Clinical Practice Outside Endemic Areas
For emergency physicians encountering a patient with unexplained bradycardia and hypotension, the consumption of exotic honey products (particularly those marketed as deli bal, wild honey, or Black Sea honey) should be included in the toxicological history. The haemodynamic picture of grayanotoxin poisoning can be mistaken for structural cardiac disease, vasovagal syncope, or other toxidrome, particularly when the honey consumption history is not volunteered. In non-endemic contexts, specific inquiry about recent honey consumption from unusual sources is warranted when the clinical picture is consistent.
The response to atropine in this context is both therapeutic and diagnostic, a rapid heart rate response to atropine in a patient with unexplained bradycardia and a history of exotic honey consumption is strongly consistent with grayanotoxin poisoning. A non-response to atropine should prompt consideration of other causes.
